Home »
Alzheimer’s disease, the most common form of dementia, is characterised by brain lesions that can cause devastating memory loss and behavioural changes. It affects some 30 million people worldwide. Decades of research have failed to produce a cure, prevention or reliable treatment. On World Alzheimer’s Day, expert Bruno Dubois tells AFP why one of the most promising avenues for treatment […]
Read more
Individuals affected by autism spectrum disorder often present communication issues and difficulties in social interactions. Although very frequent, this disorder is challenging to diagnose before the age of five. However, early care can compensate for these difficulties by providing specific behavioral intervention focused on the development of skills affected by autism. This is why an interdisciplinary team at the University […]
Read more
The early COVID-19 vaccination campaign in the U.S. prevented nearly 140,000 deaths and 3 million cases of COVID-19 by the second week of May, according to a new study. As a result of early vaccination efforts, the average state experienced five fewer deaths from COVID-19 per 10,000 adult residents. The study estimates the number of lives saved during the first […]
Read more
Researchers at University of Illinois and City University of New York have recently carried out a study investigating the effects of early acoustic experiences on gene activation in songbirds. Their paper, published in Elsevier’s journal Neuroscience Letters, shows that the early exposure to salient acoustic cues can significantly influence the development of social behaviors in songbirds. “As a behavioral ecologist […]
Read more
A Quebec research team has discovered two early plasma markers to detect Alzheimer’s disease five years before its onset. The results of this recent study led by the doctoral student Mohamed Raâfet Ben Khedher and postdoctoral student Mohamed Haddad, directed by Professor Charles Ramassamy of the Institut national de la recherche scientifique (INRS), have been published in Alzheimer’s & Dementia: […]
Read more
Statins, common cholesterol-lowering medications, may protect women’s hearts from damage caused during chemotherapy for early-stage breast cancer, according to new research published today in the Journal of the American Heart Association. “Two types of cancer medications, anthracyclines and trastuzumab, are effective treatments for many women with breast cancer, however, the risk of heart muscle damage has limited their use, particularly […]
Read more
Teens who are unhappy with their physical appearance are at significantly heightened risk of depression by the time they reach early adulthood, reveals the first UK study of its kind, published online in the Journal of Epidemiology & Community Health. The size of the increased risk ranges from 50% to 285%, the findings show, with boys more likely to experience […]
Read more
Moderna plans to have 100 to 125 million doses of its COVID-19 vaccine available in the first quarter of 2021, the vast majority of which will go to the United States, the biotechnology company announced Thursday. Between 85 and 100 million of the doses will be distributed in the United States, with the rest of the world receiving the remaining […]
Read more
One of the first spectroscopic imaging-based studies of neurological injury in COVID-19 patients has been reported by researchers at Massachusetts General Hospital (MGH) in the American Journal of Neuroradiology. Looking at six patients using a specialized magnetic resonance (MR) technique, they found that COVID-19 patients with neurological symptoms show some of the same metabolic disturbances in the brain as other […]
Read more
Pfizer provided less detail in its announcement last week on Nov. 9 than Moderna did on Monday, Nov. 16. Pfizer’s outside board of experts analyzed 94 volunteers and estimated that the effectiveness of its vaccine was over 90 percent. They did not specify how many people who got sick had received the vaccine or the placebo. Nevertheless, the estimates for […]
Read more